Amie Simmons

Cooley LLP

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Second Circuit Highlights Difficulty in Pleading Fraud Claims Involving the Interpretation of Clinical Data

Plaintiffs often file securities fraud claims against pharmaceutical companies alleging that the company misled investors about clinical data, despite the US Food and Drug Administration (FDA) subsequently approving the drug...more

1/31/2024  /  Food and Drug Administration (FDA) , Investors , Pharmaceutical Industry , Securities Fraud , Securities Litigation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide